WO2000069843A3 - Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives - Google Patents
Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives Download PDFInfo
- Publication number
- WO2000069843A3 WO2000069843A3 PCT/EP2000/004012 EP0004012W WO0069843A3 WO 2000069843 A3 WO2000069843 A3 WO 2000069843A3 EP 0004012 W EP0004012 W EP 0004012W WO 0069843 A3 WO0069843 A3 WO 0069843A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pyridofurane
- benzofurane
- urea
- derivatives
- cycloalkyl substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU47552/00A AU4755200A (en) | 1999-05-17 | 2000-05-04 | Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9911458A GB2350112A (en) | 1999-05-17 | 1999-05-17 | Pharmaceutically active cycloalkyl ketones |
GB9911458.9 | 1999-05-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000069843A2 WO2000069843A2 (en) | 2000-11-23 |
WO2000069843A3 true WO2000069843A3 (en) | 2001-02-15 |
Family
ID=10853625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/004012 WO2000069843A2 (en) | 1999-05-17 | 2000-05-04 | Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4755200A (en) |
GB (1) | GB2350112A (en) |
WO (1) | WO2000069843A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2350609C2 (en) | 2002-02-22 | 2009-03-27 | БАЙЕР ХелсКер ЛЛСи | Benzofuran and benzothiophen derivatives applied for hyperproliferative disease treatment |
US7144885B2 (en) | 2002-02-22 | 2006-12-05 | Bayer Pharmaceuticals Corporation | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
KR20070057792A (en) | 2004-07-16 | 2007-06-07 | 선에시스 파마슈티컬스 인코포레이티드 | Thienopyrimidines useful as aurora kinase inhibitors |
DE102005013621A1 (en) * | 2005-03-24 | 2006-09-28 | Curacyte Discovery Gmbh | Substituted 2-aryl (hetaryl) -5-aminothieno [2,3-d] pyrimidine-6-carboxylic acid amides, process for their preparation and use as pharmaceuticals |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0146243A1 (en) * | 1983-10-31 | 1985-06-26 | Merck Frosst Canada Inc. | Lipoxygenase inhibitors |
EP0731099A1 (en) * | 1995-03-06 | 1996-09-11 | Bayer Ag | N-(3-benzofuranyl)urea-derivatives |
EP0779291A1 (en) * | 1995-12-11 | 1997-06-18 | Bayer Ag | Heterocyclylcarbonyl substituted benzofuranyl-ureas |
WO1998002440A1 (en) * | 1996-07-12 | 1998-01-22 | Bayer Aktiengesellschaft | 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277878B1 (en) * | 1998-09-07 | 2001-08-21 | Pfizer Inc | Substituted indole compounds as anti-inflammatory and analgesic agents |
-
1999
- 1999-05-17 GB GB9911458A patent/GB2350112A/en not_active Withdrawn
-
2000
- 2000-05-04 AU AU47552/00A patent/AU4755200A/en not_active Abandoned
- 2000-05-04 WO PCT/EP2000/004012 patent/WO2000069843A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0146243A1 (en) * | 1983-10-31 | 1985-06-26 | Merck Frosst Canada Inc. | Lipoxygenase inhibitors |
EP0731099A1 (en) * | 1995-03-06 | 1996-09-11 | Bayer Ag | N-(3-benzofuranyl)urea-derivatives |
EP0779291A1 (en) * | 1995-12-11 | 1997-06-18 | Bayer Ag | Heterocyclylcarbonyl substituted benzofuranyl-ureas |
WO1998002440A1 (en) * | 1996-07-12 | 1998-01-22 | Bayer Aktiengesellschaft | 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes |
Also Published As
Publication number | Publication date |
---|---|
GB2350112A (en) | 2000-11-22 |
AU4755200A (en) | 2000-12-05 |
WO2000069843A2 (en) | 2000-11-23 |
GB9911458D0 (en) | 1999-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2301699A (en) | System for the treatment of wafers | |
ZA200106721B (en) | Process for the manufacture of furfural. | |
ZA200202461B (en) | Compounds for the treatment of ischemia. | |
WO2003035617A3 (en) | Derivatives of uk-2a | |
CY2538B1 (en) | Tetrahydropyrido compounds | |
WO2005021497A3 (en) | Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones | |
EE200100397A (en) | Compositions for the treatment of an inflammatory reaction | |
AU1044500A (en) | Imidazonaphthyridines | |
AU7622000A (en) | Compounds for the treatment of viral-mediated diseases | |
WO2001041709A3 (en) | Methods for treating cell death diseases and inflammation | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AU2376001A (en) | Method for the manufacture of olefins | |
WO2000069843A3 (en) | Cycloalkyl substituted 3-urea-benzofurane-and -pyridofurane-derivatives | |
AU2002249947A1 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
ZA9810063B (en) | Process for the manufacture of an organic compound. | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i | |
AU2002364151A1 (en) | Feedforward amplifier | |
AU4475300A (en) | Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression | |
AU2002323167A1 (en) | Substituted 7-aza(2.2.1) bicycloheptanes for the treatment of diseases | |
AU2002303821A1 (en) | Aryl-8-azabicyclo(3.2.1)octanes for the treatment of depression | |
AU2002237585A1 (en) | Method for the treatment of active sludges | |
AU2002327655A1 (en) | Substituted pyrazolo compounds for the treatment of inflammation | |
AU2002317183B2 (en) | ARYL (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence | |
AU2002311608A1 (en) | Process for the preparation of 1.1-cyclohexanediacetic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |